A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases

NAActive, not recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

January 19, 2024

Study Completion Date

December 31, 2025

Conditions
Brain Metastases
Interventions
RADIATION

6 Gy

As focal radiation techniques are utilized more frequently in the treatment of brain metastases, there is increasing need to accurately define the appropriate patient and tumor characteristics for focal therapy. Unfortunately, not all patients are good candidates for single fraction stereotactic radiosurgery (SRS) since large tumors and those in unfavorable locations have been associated with unacceptable rates of treatment-related toxicity. Five fraction stereotactic radiation has proven to be a more effective treatment for these patients that aren't good candidates.

RADIATION

7 Gy

As focal radiation techniques are utilized more frequently in the treatment of brain metastases, there is increasing need to accurately define the appropriate patient and tumor characteristics for focal therapy. Unfortunately, not all patients are good candidates for single fraction stereotactic radiosurgery (SRS) since large tumors and those in unfavorable locations have been associated with unacceptable rates of treatment-related toxicity. Five fraction stereotactic radiation has proven to be a more effective treatment for these patients that aren't good candidates.

RADIATION

8 Gy

As focal radiation techniques are utilized more frequently in the treatment of brain metastases, there is increasing need to accurately define the appropriate patient and tumor characteristics for focal therapy. Unfortunately, not all patients are good candidates for single fraction stereotactic radiosurgery (SRS) since large tumors and those in unfavorable locations have been associated with unacceptable rates of treatment-related toxicity. Five fraction stereotactic radiation has proven to be a more effective treatment for these patients that aren't good candidates.

RADIATION

9 Gy

As focal radiation techniques are utilized more frequently in the treatment of brain metastases, there is increasing need to accurately define the appropriate patient and tumor characteristics for focal therapy. Unfortunately, not all patients are good candidates for single fraction stereotactic radiosurgery (SRS) since large tumors and those in unfavorable locations have been associated with unacceptable rates of treatment-related toxicity. Five fraction stereotactic radiation has proven to be a more effective treatment for these patients that aren't good candidates.

Trial Locations (1)

35233

Hazelrig-Salter Radiation Oncology Center, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03412812 - A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases | Biotech Hunter | Biotech Hunter